{
  "@context": {
    "dct": "http://purl.org/dc/terms/",
    "owl": "http://www.w3.org/2002/07/owl#",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfa": "http://www.w3.org/ns/rdfa#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "schema": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "schema:DrugPregnancyCategory",
      "@type": "rdfs:Class",
      "rdfs:comment": "Categories that represent an assessment of the risk of fetal injury due to a drug or pharmaceutical used as directed by the mother during pregnancy.",
      "rdfs:label": "DrugPregnancyCategory",
      "rdfs:subClassOf": {
        "@id": "schema:MedicalEnumeration"
      },
      "schema:isPartOf": {
        "@id": "http://health-lifesci.schema.org"
      }
    },
    {
      "@id": "schema:FDAcategoryA",
      "@type": "schema:DrugPregnancyCategory",
      "rdfs:comment": "A designation by the US FDA signifying that adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).",
      "rdfs:label": "FDAcategoryA",
      "schema:isPartOf": {
        "@id": "http://health-lifesci.schema.org"
      }
    }
  ]
}